0.5369
price down icon2.35%   -0.0129
 
loading
前日終値:
$0.5498
開ける:
$0.55
24時間の取引高:
34,074
Relative Volume:
0.12
時価総額:
$1.83M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+32.70%
1か月 パフォーマンス:
-14.56%
6か月 パフォーマンス:
-92.46%
1年 パフォーマンス:
-99.17%
1日の値動き範囲:
Value
$0.5219
$0.57
1週間の範囲:
Value
$0.38
$0.57
52週間の値動き範囲:
Value
$0.3666
$108.00

Psyence Biomedical Ltd Stock (PBM) Company Profile

Name
名前
Psyence Biomedical Ltd
Name
セクター
Healthcare (1155)
Name
電話
-
Name
住所
-
Name
職員
10
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
PBM's Discussions on Twitter

PBM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PBM
Psyence Biomedical Ltd
0.5219 1.83M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.62 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
606.74 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.03 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
253.91 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
250.19 24.70B 3.81B -644.79M -669.77M -6.24

Psyence Biomedical Ltd (PBM) 最新ニュース

pulisher
Apr 23, 2025

Psyence Biomedical Faces Nasdaq Delisting Amid Shareholder Approval for Reverse Stock Split - TipRanks

Apr 23, 2025
pulisher
Apr 20, 2025

Psyence BioMed gets Nasdaq notice for non-compliance - MSN

Apr 20, 2025
pulisher
Apr 18, 2025

Psyence Group consolidates its shares - Crain's Chicago Business

Apr 18, 2025
pulisher
Apr 17, 2025

Psyence BioMed Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - TradingView

Apr 17, 2025
pulisher
Apr 16, 2025

Psyence BioMed invests half a million into natural psychedelics operator PsyLabs - Mugglehead Magazine

Apr 16, 2025
pulisher
Apr 15, 2025

Psyence BioMed boosts stake in PsyLabs with $500k investment By Investing.com - Investing.com Nigeria

Apr 15, 2025
pulisher
Apr 15, 2025

Psyence BioMed Announces USD$500,000 Follow-On Investment in PsyLabs and Global Ibogaine Supply Agreement - Newsfile

Apr 15, 2025
pulisher
Apr 11, 2025

Psyence Biomedical Transitions CRO for Psilocybin Trial in April 2025 - TipRanks

Apr 11, 2025
pulisher
Apr 08, 2025

Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia - Newsfile

Apr 08, 2025
pulisher
Apr 08, 2025

Major Expansion: Psyence's Breakthrough Cancer Mental Health Trial Targets Untreated Disorder - Stock Titan

Apr 08, 2025
pulisher
Apr 02, 2025

Psyence Biomedical reports corporate update By Investing.com - Investing.com Australia

Apr 02, 2025
pulisher
Apr 01, 2025

Psyence Biomedical reports corporate update - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Psyence BioMed Advances in Psychedelic Medicine with Strategic Growth and Clinical Trials - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Psyence Biomedical Announces Special Shareholder Meeting for Share Consolidation - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Psyence's Game-Changing Phase IIb Trial Takes On Cancer Mental Health Crisis - Stock Titan

Mar 31, 2025
pulisher
Mar 25, 2025

Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Further Strengthens Scientific Advisory Board With Appointment of Dr. Dan J. Stein - The Manila Times

Mar 25, 2025
pulisher
Mar 21, 2025

Psyence Biomedical Ltd. (NASDAQ:PBMWW) Short Interest Down 13.1% in February - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

Psyence Biomed expands advisory board with psychopharmacology expert By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Psyence Biomed expands advisory board with psychopharmacology expert - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

Psyence Biomed Further Strengthens Scientific Advisory Board with Appointment of Dr. Dan J. Stein - Newsfile

Mar 18, 2025
pulisher
Mar 18, 2025

Top Columbia Psychiatrist Joins Psyence's Psilocybin Clinical Trial Team - StockTitan

Mar 18, 2025
pulisher
Mar 10, 2025

Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory Board - The Manila Times

Mar 10, 2025
pulisher
Mar 06, 2025

Psyence Biomedical files to sell 13.81M common shares for holders - MSN

Mar 06, 2025
pulisher
Mar 04, 2025

Psyence Biomedical Ltd Files For Mixed Shelf Of Up To $75LN -March 04, 2025 at 04:48 pm EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Psyence Biomedical Ltd Files For Mixed Shelf Of Up To $75LN - TradingView

Mar 04, 2025
pulisher
Feb 26, 2025

Psyence Biomed Names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory Board - GlobeNewswire

Feb 26, 2025
pulisher
Feb 26, 2025

Can This Johns Hopkins Psychedelics Expert Accelerate Psyence's Psilocybin Breakthroughs? - StockTitan

Feb 26, 2025
pulisher
Feb 07, 2025

Psyence Biomedical Ltd (PBM) Stock: A Value Analysis - The News Heater

Feb 07, 2025
pulisher
Feb 06, 2025

Ratio Analysis: Unpacking Psyence Biomedical Ltd (PBM)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Feb 06, 2025
pulisher
Jan 23, 2025

Psyence Biomedical Adjusts Financials for Reverse Stock Split - TipRanks

Jan 23, 2025
pulisher
Jan 16, 2025

Short Interest in Psyence Biomedical Ltd. (NASDAQ:PBMWW) Decreases By 41.0% - Defense World

Jan 16, 2025
pulisher
Jan 05, 2025

Psyence enters into $25M common stock purchase agreement with White Lion Capital - MSN

Jan 05, 2025
pulisher
Dec 31, 2024

Psyence Biomedical Issues Pre-Funded Share Purchase Warrant - TipRanks

Dec 31, 2024
pulisher
Dec 28, 2024

Psyence Biomed Announces Closing of $2.0 Million Private Placement - The Manila Times

Dec 28, 2024
pulisher
Dec 27, 2024

Psyence Biomed (PBM) Raises $2M in Private Placement with Warrant Coverage, Led by H.C. Wainwright - StockTitan

Dec 27, 2024
pulisher
Dec 24, 2024

Psyence Biomedical Regains Nasdaq Compliance, Fortifying Market Position - Yahoo Finance

Dec 24, 2024
pulisher
Dec 24, 2024

Psyence Biomed announces $2 million private placement By Investing.com - Investing.com Nigeria

Dec 24, 2024

Psyence Biomedical Ltd (PBM) 財務データ

Psyence Biomedical Ltd (PBM) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.65
price up icon 0.63%
$70.47
price up icon 1.28%
$32.49
price up icon 0.64%
$23.90
price up icon 1.85%
$108.35
price up icon 3.89%
biotechnology ONC
$247.87
price up icon 1.21%
大文字化:     |  ボリューム (24 時間):